
Patients living with GERD now have a new treatment option for improved and sustained symptom relief
DEXILANT is the First Proton Pump Inhibitor (PPI) with a DUAL DELAYED RELEASE (DDR) Technology
MISSISSAUGA, ON, Sept. 23 /PRNewswire/ - To view this Social Media Release, please enter the following address in your web browser.
http://smr.newswire.ca/en/takeda-canada-inc/patients-living-with-gerd-now-have-a-new-treatment
SOURCE University of Guelph
Share this article